Antihypertensive Medication Classes Used among Medicare Beneficiaries Initiating Treatment in 2007–2010

• Shia T. Kent ,

  * E-mail: shia@uab.edu

  Affiliation Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Daichi Shimbo,

  Affiliation Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Lei Huang,

  Affiliation Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Keith M. Diaz,

  Affiliation Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Meredith L. Kilgore,

  Affiliation Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Suzanne Oparil,

  Affiliation Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Paul Muntner

  Affiliations Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯